baicalein 5,6,7-trimethyl ether
stimulates fatty acid beta-oxidation; structure in first source
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Morita, Masashi:
2 articles
(07/2007 - 01/2005)
|
2. | Hayashi, T:
1 article
(06/2008)
|
3. | Imanaka, T:
1 article
(06/2008)
|
4. | Iwashima, M:
1 article
(06/2008)
|
5. | Kanai, M:
1 article
(06/2008)
|
6. | Mizuno, S:
1 article
(06/2008)
|
7. | Morita, M:
1 article
(06/2008)
|
8. | Shimozawa, N:
1 article
(06/2008)
|
9. | Suzuki, Y:
1 article
(06/2008)
|
10. | Furuya, Hirokazu:
1 article
(01/2005)
|
Related Diseases
1. | Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked)
06/01/2008
- " Recently, we reported that baicalein 5,6,7-trimethyl ether (BTM), a flavonoid, is capable of activating fatty acid beta-oxidation in X-linked adrenoleukodystrophy (X-ALD) fibroblasts (FEBS Lett. " 07/01/2007
- " We found that baicalein 5,6,7-trimethyl ether, a flavonoid derivative, decreased the VLCFA level in X-ALD fibroblasts, possibly by activating peroxisomal fatty acid beta-oxidation. " 01/17/2005
- " Baicalein 5,6,7-trimethyl ether, a flavonoid derivative, stimulates fatty acid beta-oxidation in skin fibroblasts of X-linked adrenoleukodystrophy."
|
|
Related Drugs and Biologics